EATCL

(redirected from Enteropathy-Associated T-Cell Lymphoma)
AcronymDefinition
EATCLEnteropathy-Associated T-Cell Lymphoma
References in periodicals archive ?
Type II enteropathy-associated T-cell lymphoma is a subset of EATL which does not appear to be associated with celiac disease and therefore has a broader geographic distribution.
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma.
High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma.
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.
Enteropathy-associated T-cell lymphoma - A clinicopathologic and array comparative genomic hybridization study.
Enteropathy-associated T-cell lymphoma most commonly presents in patients with a short history of adult-onset celiac disease or the celiac disease-associated condition dermatitis herpetiformis.
Enteropathy-associated T-cell lymphoma may have occasional pleomorphic cells; however, it does not typically have horseshoe-shaped cells.
Enteropathy-associated T-cell lymphoma is a rare type of lymphoma that should be considered when encountering a non-Hodgkin lymphoma of the gastrointestinal tract.
Summary of enteropathy-associated T-cell lymphoma (EATL) characteristics.
Classic enteropathy-associated T-cell lymphoma (hematoxylin-eosin, original magnifications X5 [A], X400 [B], and X60 [C]).
Type II enteropathy-associated T-cell lymphoma (hematoxylin-eosin, original magnifications X5 [A], X400 [B], and X200 [C]).